News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Anita Afzali: Ozanimod for moderate to severe ulcerative colitis
Photo taken from Anita Afzali/X
Jun 8, 2024, 02:27

Anita Afzali: Ozanimod for moderate to severe ulcerative colitis

Anita Afzali, Executive Vice Chair of the University of Cincinnati College of Medicine, shared a post on X:

“Our Pub Alert – Ozanimod for moderate to severe ulcerative colitis in patients naive to advanced therapies
Take a read.”

Anita Afzali

Read further.
Source: Anita Afzali/X 

Anita Afzali cancer OncoDaily Oncology ulcerative colitis
Special Coverage
Insight
Sep 1, 2024, 04:35
Heloisa Soares: Thrilled to attend my first ASCO Government Relations Committee meeting!
Insight
Sep 1, 2024, 04:23
Joaquim Bellmunt: Proud of learning from negative trials
Blog
Sep 1, 2024, 03:57
Paulo G. Bergerot discussing Exercise for People with Advanced Cancer at WCLC24
Insight
Sep 1, 2024, 03:04
Insights on the evidence of immunotherapy in hereditary cancers from 2nd edition of the National Cancer Centre Singapore’s Grand Rounds
Insight
Aug 31, 2024, 23:14
David Zaas: Teammate Appreciation Week at Atrium Health Wake Forest Baptist
Blog
Aug 31, 2024, 20:21
Robin Zon: Great Day at ASCO HQ
Opinion
Aug 31, 2024, 20:15
Amol Akhade: Puxitatug samrotecan probably looks most promising among the new ADC data coming up from ESMO 24
Insight
Aug 31, 2024, 20:07
5 papers about lung cancer suggested by Stephen Liu
Blog
Aug 31, 2024, 19:25
Lucas Family's Fight Against Childhood Cancer
Blog
Aug 31, 2024, 18:55
Miriam Mutebi: Caregivers play a vital role in the cancer care journey
Blog
Aug 31, 2024, 18:36
Asaf Maoz: Looking Back, Facing Forward is coming up September 14th
Insight
Aug 31, 2024, 18:34
Erman Akkus: First line treatment of metastatic Colorectal Cancer in older patients